class action lawsuit

Law firm Hagens Berman investigates CoreWeave for allegedly misleading investors about AI infrastructure capacity and concealing Denton facility delays, triggering $14 billion market cap decline.

Law firm Bernstein Liebhard files class action lawsuit against Corcept Therapeutics for alleged material misrepresentations about relacorilant drug clinical evidence.

Bernstein Liebhard files class action lawsuit against Zynex for alleged overbilling scheme artificially inflating revenue from 2018-2023. Affected shareholders urged to evaluate legal options.

REGENXBIO faces class action lawsuit alleging false statements about gene therapy RGX-111's safety and efficacy. Investors must act by April 14, 2026 deadline.

Kyndryl faces class action lawsuit for allegedly issuing false financial statements and maintaining inadequate accounting controls, following a 50% stock drop in February 2026.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

BellRing Brands faces class action lawsuit alleging it misrepresented sales growth as organic demand when it actually stemmed from customer inventory restocking following supply chain disruptions.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements, insider share sales, and social media misinformation to artificially inflate stock price.

REGENXBIO faces class action lawsuit alleging executives made false statements about RGX-111 gene therapy's efficacy and safety, seeking shareholder damages.

PomDoctor faces class action lawsuit alleging fraudulent stock promotion scheme involving false statements, insider sales, and market manipulation between October-December 2025.

Enphase Energy faces class action lawsuit for allegedly misleading investors about inventory management and tax credit expiration impact during April-October 2025.

Class action lawsuit filed against Vistagen Therapeutics for alleged false statements regarding drug trial data. Investors who purchased securities April 2024-December 2025 may be eligible.

Kyndryl faces class action lawsuit alleging false financial statements and internal control weaknesses from August 2024 to February 2026, affecting investors who purchased securities during this period.

PayPal faces class action lawsuit alleging executives made false statements about revenue projections and 2027 financial targets, failing to disclose material risks to investors.

uniQure faces class action lawsuit alleging misleading statements about FDA study status and BLA timeline delays. Investors who purchased shares Sept-Oct 2025 may be eligible to claim.

Portnoy Law Firm sues Richtech Robotics for falsely claiming Microsoft partnership. Stock fell 29% after Microsoft denied commercial relationship, causing investor losses.

Investors sued Ramaco Resources for allegedly misleading statements about Brook Mine operations between July-October 2025, claiming false progress claims.

Schall Law Firm sues Richtech Robotics for allegedly misrepresenting Microsoft partnerships. Investors who bought stock January 27-29, 2026 sought as plaintiffs.

Law firm launches investigation into Alpine Lumber ransomware attack that exposed customer data including Social Security numbers and financial details, exploring class action litigation.

PayPal faces securities lawsuit over allegedly false 2027 guidance and checkout platform claims. Investors who bought stock Feb 2025-Feb 2026 may seek compensation.